ST
BVS icon

Sphinx Trading’s Bioventus BVS Stock Holding History

Sphinx Trading’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-601
Closed -$9K – 150
2021
Q3 		$9K Buy
+601
New +$9.25K 0.01% 130

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Sphinx Trading's BVS Position: Q4 2021 in Review

Sphinx Trading sold out of Bioventus (BVS) in Q4 2021, closing a stake of 601 shares — an estimated $9K sold.

Sphinx Trading first reported a position in BVS in Q3 2021 and held it in 1 quarter. The position peaked at $9K in Q3 2021. 98 funds tracked by Wall St. Rank hold BVS as of Q4 2021.

  • Sphinx Trading reported no remaining Bioventus position as of Q4 2021 after selling out during the quarter.
  • Sphinx Trading sold 601 Bioventus shares in Q4 2021, an estimated $9K.
  • Sphinx Trading first reported a position in Bioventus in Q3 2021 and held it in 1 quarter.
  • Sphinx Trading's Bioventus position peaked at $9K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Bioventus as of Q4 2021.

Based on Sphinx Trading's 13F filing for Q4 2021, filed 31 Jan 2022.